Codexis (CDXS) Gross Profit (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Codexis | 251.43 Mn | 186.29 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.24% |
| Dec 31, 2025 | 500.91% |
| Sep 30, 2025 | -53.62% |
| Jun 30, 2025 | 174.99% |
| Mar 31, 2025 | -72.98% |
| Dec 31, 2024 | 109.09% |
| Sep 30, 2024 | 88.53% |
| Jun 30, 2024 | -63.03% |
| Mar 31, 2024 | 471.47% |
| Dec 31, 2023 | -69.58% |
| Sep 30, 2023 | 285.73% |
| Jun 30, 2023 | -78.47% |
| Mar 31, 2023 | -25.41% |
| Dec 31, 2022 | -54.04% |
| Sep 30, 2022 | -9.04% |
| Jun 30, 2022 | 1.18% |
| Mar 31, 2022 | 51.56% |
| Dec 31, 2021 | -40.82% |
| Sep 30, 2021 | 41.48% |
| Jun 30, 2021 | 53.00% |
| Mar 31, 2021 | -8.96% |
| Dec 31, 2020 | 2.92% |
| Sep 30, 2020 | 11.12% |
| Jun 30, 2020 | 9.39% |
| Mar 31, 2020 | -20.46% |
| Dec 31, 2019 | -9.45% |
| Sep 30, 2019 | 76.38% |
| Jun 30, 2019 | -14.70% |
| Mar 31, 2019 | -18.16% |
| Dec 31, 2018 | 3.96% |
| Sep 30, 2018 | 20.39% |
| Jun 30, 2018 | 6.95% |
| Mar 31, 2018 | -43.75% |
| Dec 31, 2017 | 202.33% |
| Sep 30, 2017 | 272.15% |
| Jun 30, 2017 | -235.06% |
| Mar 31, 2017 | -66.36% |
| Dec 31, 2016 | -36.59% |
| Sep 30, 2016 | -12.10% |
| Jun 30, 2016 | 150.25% |
| Mar 31, 2016 | -38.87% |
| Dec 31, 2015 | 1,645.93% |
| Sep 30, 2015 | -32.99% |
| Jun 30, 2015 | -52.47% |
| Mar 31, 2015 | 35.68% |
| Dec 31, 2014 | -79.90% |
| Sep 30, 2014 | 809.65% |
| Jun 30, 2014 | -85.65% |
| Mar 31, 2014 | 811.82% |
| Dec 31, 2013 | -85.53% |
| Sep 30, 2013 | 161.88% |
| Jun 30, 2013 | -62.07% |
| Mar 31, 2013 | 62.78% |
| Dec 31, 2012 | 187.08% |
| Sep 30, 2012 | 113.34% |
| Jun 30, 2012 | -130.12% |
| Mar 31, 2012 | -9.46% |
| Dec 31, 2011 | 811.51% |
| Sep 30, 2011 | 132.80% |
| Jun 30, 2011 | -135.25% |
| Mar 31, 2011 | -10.61% |
| Dec 31, 2010 | 16.90% |
| Sep 30, 2010 | 670.03% |